Neil H. Segal, M.D., Ph.D. Assistant Attending Gastrointestinal Oncology Service and Immunotherapeutics Core Memorial Sloan-Kettering Cancer Center.
VIROTEAM 10-12 Septembre2015 Marseille. HIV-1–specific T-cell responses in exposed seronegative subjects suggest that a viral breach of the exposure site.
T-cell HIV Vaccines Giuseppe Pantaleo, M.D. Professor of Medicine Director, Swiss Vaccine Research Institute Lausanne, Switzerland.
Tetramer analysis by Sadegh feizollahzadeh. 1.Monitoring vaccine studies 2.Monitoring effect of Immunotherapy 3.Monitoring T-cell responses in infectious.
